UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy

Nature (London), 2019-08, Vol.572 (7769), p.392-396

2019

Volltextzugriff (PDF)

CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients

Immunity (Cambridge, Mass.), 2010-01, Vol.32 (1), p.129-140

2010

Volltextzugriff (PDF)

Targeted Intervention of NF2–YAP Signaling Axis in CD24-Overexpressing Cells Contributes to Encouraging Therapeutic Effects in TNBC

ACS nano, 2022-04, Vol.16 (4), p.5807-5819

2022

Volltextzugriff (PDF)

CD24-Siglec axis is an innate immune checkpoint against metaflammation and metabolic disorder

Cell metabolism, 2022-08, Vol.34 (8), p.1088-1103.e6

2022

Volltextzugriff (PDF)

CD24 is a marker of exosomes secreted into urine and amniotic fluid

Kidney international, 2007-11, Vol.72 (9), p.1095-1102

2007

Volltextzugriff (PDF)

Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis

Scientific reports, 2017-10, Vol.7 (1), p.13856-15, Article 13856

2017

Volltextzugriff (PDF)

Intrathymic programming of effector fates in three molecularly distinct γδ T cell subtypes

Nature immunology, 2012-05, Vol.13 (5), p.511-518

2012

Volltextzugriff (PDF)

A highly potent small-molecule antagonist of exportin-1 selectively eliminates CD44+CD24- enriched breast cancer stem-like cells

Drug resistance updates, 2023-01, Vol.66, p.100903-100903, Article 100903

2023

Volltextzugriff (PDF)

Involvement of CD24 in Multiple Cancer Related Pathways Makes It an Interesting New Target for Cancer Therapy

Current cancer drug targets, 2018-05, Vol.18 (4), p.328-336

2018

Volltextzugriff (PDF)

Batf3 maintains autoactivation of Irf8 for commitment of a CD8α(+) conventional DC clonogenic progenitor

Nature immunology, 2015-07, Vol.16 (7), p.708-717

2015

Volltextzugriff (PDF)

The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors

The Journal of clinical investigation, 2011-07, Vol.121 (7), p.2723-2735

2011

Volltextzugriff (PDF)

Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM

Gynecologic oncology, 2007-12, Vol.107 (3), p.563-571

2007

Volltextzugriff (PDF)

SIRT1-Mediated Expression of CD24 and Epigenetic Suppression of Novel Tumor Suppressor miR-1185-1 Increases Colorectal Cancer Stemness

Cancer research (Chicago, Ill.), 2020-12, Vol.80 (23), p.5257-5269

2020

Volltextzugriff (PDF)

GATA3 Encapsulated by Tumor-Associated Macrophage-Derived Extracellular Vesicles Promotes Immune Escape and Chemotherapy Resistance of Ovarian Cancer Cells by Upregulating the CD24/Siglec-10 Axis

Molecular pharmaceutics, 2023-02, Vol.20 (2), p.971-986

2023

Volltextzugriff (PDF)

Expression of CD24 and Siglec-10 in first trimester placenta: implications for immune tolerance at the fetal–maternal interface

Histochemistry and cell biology, 2017-05, Vol.147 (5), p.565-574

2017

Volltextzugriff (PDF)

A CD24‐p53 axis contributes to African American prostate cancer disparities

The Prostate, 2020-05, Vol.80 (8), p.609-618

2020

Volltextzugriff (PDF)

Generation of breast cancer stem cells through epithelial-mesenchymal transition

PloS one, 2008-08, Vol.3 (8), p.e2888-e2888

2008

Volltextzugriff (PDF)

CD24 targeting with NK-CAR immunotherapy in testis, prostate, renal and (luminal-type) bladder cancer and identification of direct CD24 interaction partners

The FEBS journal, 2023-10, Vol.290 (20), p.4864-4876

2023

Volltextzugriff (PDF)

CD24 controls Src/STAT3 activity in human tumors

Cellular and molecular life sciences : CMLS, 2012-11, Vol.69 (22), p.3863-3879

2012

Volltextzugriff (PDF)

Impeding Transcription of Expanded Microsatellite Repeats by Deactivated Cas9

Molecular cell, 2017-11, Vol.68 (3), p.479-490.e5

2017

Volltextzugriff (PDF)

Phenotypic and molecular states of IDH1 mutation-induced CD24-positive glioma stem-like cells

Neoplasia (New York, N.Y.), 2022-06, Vol.28, p.100790-100790, Article 100790

2022

Volltextzugriff (PDF)

CD24 regulates cancer stem cell (CSC)-like traits and a panel of CSC-related molecules serves as a non-invasive urinary biomarker for the detection of bladder cancer

British journal of cancer, 2018-10, Vol.119 (8), p.961-970

2018

Volltextzugriff (PDF)

More than markers: biological significance of cancer stem cell-defining molecules

Molecular cancer therapeutics, 2010-09, Vol.9 (9), p.2450-2457

2010

Volltextzugriff (PDF)

Unravelling CD24‐Siglec‐10 pathway: Cancer immunotherapy from basic science to clinical studies

Immunology, 2024-11, Vol.173 (3), p.442-469

2024

Volltextzugriff (PDF)

Significance of CD44 and CD24 as Cancer Stem Cell Markers : An Enduring Ambiguity

Clinical & developmental immunology, 2012-01, Vol.2012 (2012), p.1-11

2012

Volltextzugriff (PDF)

1 – 25 von 1.476

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.358)
Mit Volltextzugriff
(1.318)

Publikationsform

Artikel
(1.474)
Buchkapitel
(2)

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy

CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients

Targeted Intervention of NF2–YAP Signaling Axis in CD24-Overexpressing Cells Contributes to Encouraging Therapeutic Effects in TNBC

CD24-Siglec axis is an innate immune checkpoint against metaflammation and metabolic disorder

CD24 is a marker of exosomes secreted into urine and amniotic fluid

Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis

Intrathymic programming of effector fates in three molecularly distinct γδ T cell subtypes

A highly potent small-molecule antagonist of exportin-1 selectively eliminates CD44+CD24- enriched breast cancer stem-like cells

Involvement of CD24 in Multiple Cancer Related Pathways Makes It an Interesting New Target for Cancer Therapy

Batf3 maintains autoactivation of Irf8 for commitment of a CD8α(+) conventional DC clonogenic progenitor

The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors

Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM

SIRT1-Mediated Expression of CD24 and Epigenetic Suppression of Novel Tumor Suppressor miR-1185-1 Increases Colorectal Cancer Stemness

GATA3 Encapsulated by Tumor-Associated Macrophage-Derived Extracellular Vesicles Promotes Immune Escape and Chemotherapy Resistance of Ovarian Cancer Cells by Upregulating the CD24/Siglec-10 Axis

Expression of CD24 and Siglec-10 in first trimester placenta: implications for immune tolerance at the fetal–maternal interface

A CD24‐p53 axis contributes to African American prostate cancer disparities

Generation of breast cancer stem cells through epithelial-mesenchymal transition

CD24 targeting with NK-CAR immunotherapy in testis, prostate, renal and (luminal-type) bladder cancer and identification of direct CD24 interaction partners

CD24 controls Src/STAT3 activity in human tumors

Impeding Transcription of Expanded Microsatellite Repeats by Deactivated Cas9

Phenotypic and molecular states of IDH1 mutation-induced CD24-positive glioma stem-like cells

CD24 regulates cancer stem cell (CSC)-like traits and a panel of CSC-related molecules serves as a non-invasive urinary biomarker for the detection of bladder cancer

More than markers: biological significance of cancer stem cell-defining molecules

Unravelling CD24‐Siglec‐10 pathway: Cancer immunotherapy from basic science to clinical studies

Significance of CD44 and CD24 as Cancer Stem Cell Markers : An Enduring Ambiguity

Suchergebnisse filtern